Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 4
1967 8
1968 7
1969 7
1970 7
1971 8
1972 2
1973 6
1974 3
1975 8
1976 7
1977 9
1978 8
1979 10
1980 13
1981 12
1982 17
1983 11
1984 19
1985 12
1986 12
1987 12
1988 18
1989 35
1990 31
1991 26
1992 15
1993 25
1994 21
1995 29
1996 25
1997 26
1998 25
1999 45
2000 55
2001 50
2002 44
2003 37
2004 41
2005 39
2006 45
2007 40
2008 28
2009 21
2010 20
2011 15
2012 17
2013 15
2014 14
2015 14
2016 15
2017 8
2018 5
2019 4
2020 10
2021 5
2022 8
2023 8
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

1,034 results

Results by year

Filters applied: . Clear all
Page 1
The menopause.
Gambrell RD Jr. Gambrell RD Jr. Invest Radiol. 1986 Apr;21(4):369-78. doi: 10.1097/00004424-198604000-00017. Invest Radiol. 1986. PMID: 3516923 Review.
Norethindrone acetate and estradiol-induced endometrial hyperplasia.
Kurman RJ, Félix JC, Archer DF, Nanavati N, Arce J, Moyer DL. Kurman RJ, et al. Obstet Gynecol. 2000 Sep;96(3):373-9. doi: 10.1016/s0029-7844(00)00944-3. Obstet Gynecol. 2000. PMID: 10960628 Free article. Clinical Trial.
OBJECTIVE: To identify the lowest effective continuous dose of norethindrone acetate that significantly reduces 12-month incidence of endometrial hyperplasia associated with unopposed 17beta-estradiol (E2), 1 mg. ...RESULTS: Continuous-combined E2-norethindrone acet …
OBJECTIVE: To identify the lowest effective continuous dose of norethindrone acetate that significantly reduces 12-month incidence of …
Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.
Kamischke A, Venherm S, Plöger D, von Eckardstein S, Nieschlag E. Kamischke A, et al. J Clin Endocrinol Metab. 2001 Jan;86(1):303-9. doi: 10.1210/jcem.86.1.7057. J Clin Endocrinol Metab. 2001. PMID: 11232016 Clinical Trial.
However, the efficacy of most trials remained disappointing. Norethisterone enanthate (NETE) has been used as a long-acting injectable female contraceptive and has shown sustained suppression of spermatogenesis in male monkeys and prolonged suppression of gonadotropins in …
However, the efficacy of most trials remained disappointing. Norethisterone enanthate (NETE) has been used as a long-acting injectabl …
Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).
Andino N. Andino N. Contraception. 1981 Feb;23(2):141-55. doi: 10.1016/0010-7824(81)90100-1. Contraception. 1981. PMID: 6786825 Clinical Trial.
A Phase I Clinical Trial was conducted in 20 fertile Cuban women using for contraception: Norethisterone Enanthate injectable (NEN) and Norethisterone Acetate minipill (NET). Women had daily blood sampling during a control cycle and during the second month of treatm …
A Phase I Clinical Trial was conducted in 20 fertile Cuban women using for contraception: Norethisterone Enanthate injectable (NEN) a …
A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women.
Lukes A, Migoya E, Johnson B, Lee TY, Li Y, Arjona Ferreira JC. Lukes A, et al. Clin Pharmacokinet. 2023 Aug;62(8):1169-1182. doi: 10.1007/s40262-023-01269-9. Epub 2023 Jun 26. Clin Pharmacokinet. 2023. PMID: 37365436 Free PMC article. Clinical Trial.
This study assessed whether the addition of estradiol (E2) 1 mg and norethindrone acetate (NETA) 0.5 mg to relugolix 40 mg (relugolix combination therapy) provides systemic E2 concentrations in the 20-50 pg/mL range to minimize these undesirable effects. ...Study assessmen …
This study assessed whether the addition of estradiol (E2) 1 mg and norethindrone acetate (NETA) 0.5 mg to relugolix 40 mg (relugolix …
The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
Hendrix CW, Jackson KA, Whitmore E, Guidos A, Kretzer R, Liss CM, Shah LP, Khoo KC, McLane J, Trapnell CB. Hendrix CW, et al. Clin Pharmacol Ther. 2004 May;75(5):464-75. doi: 10.1016/j.clpt.2004.01.003. Clin Pharmacol Ther. 2004. PMID: 15116059 Clinical Trial.
The pharmacokinetics of ethinyl estradiol and norethindrone (INN, norethisterone) (the components of Ortho Novum 7/7/7; Ortho-McNeil Pharmaceutical, Inc, Raritan, NJ) and pharmacodynamic assessments of oral contraceptive effectiveness (concentrations of serum proges …
The pharmacokinetics of ethinyl estradiol and norethindrone (INN, norethisterone) (the components of Ortho Novum 7/7/7; Ortho- …
Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN.
Avenant C, Bick AJ, Skosana SB, Dlamini S, Balakrishna Y, Moliki JM, Singata-Madliki M, Hofmeyr GJ, Smit J, Beksinska M, Beesham I, Seocharan I, Batting J, Chen PL, Storbeck KH, Africander D, Hapgood JP. Avenant C, et al. PLoS One. 2023 Dec 22;18(12):e0295959. doi: 10.1371/journal.pone.0295959. eCollection 2023. PLoS One. 2023. PMID: 38134043 Free PMC article. Clinical Trial.
The WHICH clinical trial randomized HIV-negative women to DMPA-IM (n = 262) or norethisterone enanthate (NET-EN) (n = 259) at two South African sites between 2018-2019. We measured serum concentrations of study and non-study progestins at initiation (D0) and peak serum lev …
The WHICH clinical trial randomized HIV-negative women to DMPA-IM (n = 262) or norethisterone enanthate (NET-EN) (n = 259) at two Sou …
The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial.
Avenant C, Singata-Madliki M, Bick AJ, Africander D, Balakrishna Y, Storbeck KH, Moliki JM, Dlamini S, Skosana S, Smit J, Beksinska M, Beesham I, Seocharan I, Batting J, Hofmeyr GJ, Hapgood JP. Avenant C, et al. PLoS One. 2024 Aug 23;19(8):e0307736. doi: 10.1371/journal.pone.0307736. eCollection 2024. PLoS One. 2024. PMID: 39178280 Free PMC article. Clinical Trial.
HIV acquisition risk with norethisterone (NET) enanthate (NET-EN) is reportedly less than for depo-medroxyprogesterone acetate intramuscular (DMPA-IM). ...
HIV acquisition risk with norethisterone (NET) enanthate (NET-EN) is reportedly less than for depo-medroxyprogesterone acetate intram …
Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.
Ailawadi RK, Jobanputra S, Kataria M, Gurates B, Bulun SE. Ailawadi RK, et al. Fertil Steril. 2004 Feb;81(2):290-6. doi: 10.1016/j.fertnstert.2003.09.029. Fertil Steril. 2004. PMID: 14967362 Clinical Trial.
Oral administration of letrozole (2.5 mg), the progestin norethindrone acetate (2.5 mg), calcium citrate (1,250 mg), and vitamin D (800 IU) was done daily for 6 months. ...CONCLUSION(S): The combination of letrozole and norethindrone acetate achieved marked reductio …
Oral administration of letrozole (2.5 mg), the progestin norethindrone acetate (2.5 mg), calcium citrate (1,250 mg), and vitamin D (8 …
Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
[No authors listed] [No authors listed] Contraception. 1983 Jul;28(1):1-20. doi: 10.1016/s0010-7824(83)80002-x. Contraception. 1983. PMID: 6226488 Clinical Trial.
Final results are presented from a two-year WHO multinational comparative trial of three regimens: depot-medroxyprogesterone acetate (DMPA) given at 90-day intervals, norethisterone enanthate (NET-EN) given at 60-day intervals for the entire study period (NET-EN (60-day)), …
Final results are presented from a two-year WHO multinational comparative trial of three regimens: depot-medroxyprogesterone acetate (DMPA) …
1,034 results